Literature DB >> 18615900

Soluble RAGE, diabetic nephropathy and genetic variability in the AGER gene.

Katerina Kanková1, Marta Kalousová, Miluse Hertlová, Darja Krusová, Jindrich Olsovský, Tomás Zima.   

Abstract

Diabetes mellitus, especially when complicated with decline of renal function due to diabetic nephropathy (DN), is associated with accumulation of advanced glycation end products (AGEs) exerting their adverse effects via receptor of AGE (RAGE). Soluble RAGE (sRAGE) is a truncated form of RAGE functioning as an inhibitor of AGE-mediated signalling. We studied relationships between sRAGE, renal function and genetic variability in the AGER gene in diabetic subjects. Study comprised a total of 265 diabetics (type 1 or 2 or LADA) with normoalbuminuria (n = 94) or DN (n = 171). sRAGE (assessed by ELISA) was significantly higher in DN than normoalbuminuria subjects (P = 0.007) and positively correlated with age, S-urea, S-creatinine and albuminuria and AGEs (determined spectrofluorimetrically), negatively with GFR (all P < 0.05); however, multivariate regression revealed that GFR was the only independent variable associated with sRAGE (P = 0.047). sRAGE did not correspond with carrier state of risk-haplotype copies (RAGE2) (P > 0.05). In conclusion, GFR is a principal determinant of sRAGE concentration and gradual sRAGE increase in subjects with advancing impairment of renal function is paralleled by AGEs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18615900     DOI: 10.1080/13813450802033818

Source DB:  PubMed          Journal:  Arch Physiol Biochem        ISSN: 1381-3455            Impact factor:   4.076


  11 in total

1.  Racial differences in circulating levels of the soluble receptor for advanced glycation endproducts in middle-aged and older adults.

Authors:  Tina E Brinkley; Xiaoyan Leng; Barbara J Nicklas; Stephen B Kritchevsky; Jingzhong Ding; Dalane W Kitzman; W Gregory Hundley
Journal:  Metabolism       Date:  2017-02-10       Impact factor: 8.694

Review 2.  RAGE and the pathogenesis of chronic kidney disease.

Authors:  Vivette D'Agati; Ann Marie Schmidt
Journal:  Nat Rev Nephrol       Date:  2010-04-27       Impact factor: 28.314

3.  Soluble receptor for AGE (RAGE) is a novel independent predictor of all-cause and cardiovascular mortality in type 1 diabetes.

Authors:  M C Thomas; J Söderlund; M Lehto; V-P Mäkinen; J L Moran; M E Cooper; C Forsblom; P-H Groop
Journal:  Diabetologia       Date:  2011-05-24       Impact factor: 10.122

4.  Microalbuminuria and sRAGE in high-risk hypertensive patients treated with nifedipine/telmisartan combination treatment: a substudy of TALENT.

Authors:  Colomba Falcone; Maria Paola Buzzi; Sara Bozzini; Chiara Boiocchi; Angela D'Angelo; Sandra Schirinzi; Ciro Esposito; Massimo Torreggiani; Jasmine Choi; Michael Ochan Kilama; Giuseppe Mancia
Journal:  Mediators Inflamm       Date:  2012-02-13       Impact factor: 4.711

5.  Critical Appraisal of Advanced Glycation End Products (AGEs) and Circulating Soluble Receptors for Advanced Glycation End Products (sRAGE) as a Predictive Biomarkers for Cardiovascular Disease in Hemodialysis Patients.

Authors:  Adel M A Assiri; Hala F M Kamel; Abeer A ALrefai
Journal:  Med Sci (Basel)       Date:  2018-05-22

6.  Metabolic dysfunction in Emirati subjects in Abu Dhabi: Relationship to levels of soluble RAGEs.

Authors:  Abdishakur Abdulle; Claire K Inman; Abdelkarim Saleh; Mohamed Noshi; Divya Galani; Laila Abdelwareth; Habiba Alsafar; Abubaker Elfatih; Hefsa Al Shamsi; Raghib Ali; Huilin Li; Ravichandran Ramasamy; Ann Marie Schmidt; Mahmoud M Benbarka; Mohamed H Hassan
Journal:  J Clin Transl Endocrinol       Date:  2019-04-23

7.  Soluble receptor for AGE in diabetic nephropathy and its progression in Finnish individuals with type 1 diabetes.

Authors:  Jenny M Wadén; Emma H Dahlström; Nina Elonen; Lena M Thorn; Johan Wadén; Niina Sandholm; Carol Forsblom; Per-Henrik Groop
Journal:  Diabetologia       Date:  2019-05-24       Impact factor: 10.122

Review 8.  Pathological Implications of Receptor for Advanced Glycation End-Product (AGER) Gene Polymorphism.

Authors:  Marine Serveaux-Dancer; Matthieu Jabaudon; Isabelle Creveaux; Corinne Belville; Raïko Blondonnet; Christelle Gross; Jean-Michel Constantin; Loïc Blanchon; Vincent Sapin
Journal:  Dis Markers       Date:  2019-02-04       Impact factor: 3.434

9.  Skin autofluorescence relates to soluble receptor for advanced glycation end-products and albuminuria in diabetes mellitus.

Authors:  J Skrha; J Soupal; G Loni Ekali; M Prázný; M Kalousová; J Kvasnička; L Landová; T Zima; J Skrha
Journal:  J Diabetes Res       Date:  2013-03-10       Impact factor: 4.011

10.  Effect of glycemic control on soluble RAGE and oxidative stress in type 2 diabetic patients.

Authors:  Tarek Mk Motawi; Mohamed A Abou-Seif; Ahmed Ma Bader; Mohamed O Mahmoud
Journal:  BMC Endocr Disord       Date:  2013-08-21       Impact factor: 2.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.